View by Specialty

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

Infection News

SPONSORED CONTENT
January 06, 2025
2 min read
Save
Long term autoimmune, autoinflammatory disease risk significantly higher after COVID-19

Long term autoimmune, autoinflammatory disease risk significantly higher after COVID-19

SARS-CoV-2 infection, especially a severe case or without vaccination, significantly increases the long-term risk for developing autoimmune and autoinflammatory connective tissue diseases, according to data published in JAMA Dermatology.

SPONSORED CONTENT
December 09, 2024
2 min read
Save

Severe infection, rituximab use predict long COVID in patients with autoimmune disease

Severe infection, rituximab use predict long COVID in patients with autoimmune disease

WASHINGTON — Severe acute COVID-19 infection, as well as glucocorticoid and rituximab use, increase the risk for long COVID in patients with autoimmune rheumatic diseases, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
November 26, 2024
2 min read
Save

Post-exertional malaise assessment ‘becoming more important’ for long COVID in rheum care

Post-exertional malaise assessment ‘becoming more important’ for long COVID in rheum care

WASHINGTON — Approximately 20% of patients meeting the 2016 fibromyalgia criteria report post-exertional malaise, which itself may be key to understanding both long COVID and fatigue in patients with rheumatic diseases, according to data.

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

SPONSORED CONTENT
November 25, 2024
2 min read
Save

Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease

Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease

WASHINGTON — The correlation between autoantibodies and new-onset autoimmune disease in individuals with long COVID symptoms remains “controversial,” according to a speaker at ACR Convergence 2024.

SPONSORED CONTENT
November 19, 2024
2 min read
Save

Low IL-18 levels may predict long COVID risk in systemic autoimmune rheumatic diseases

Low IL-18 levels may predict long COVID risk in systemic autoimmune rheumatic diseases

WASHINGTON — Among patients with systemic autoimmune rheumatic diseases, circulating interleukin-18 levels were lower in those with long COVID vs. those without, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
November 18, 2024
2 min read
Save

IL-6, JAK inhibitors, rituximab increase severe infection risk in inflammatory arthritis

IL-6, JAK inhibitors, rituximab increase severe infection risk in inflammatory arthritis

WASHINGTON — Patients with inflammatory arthritis who receive rituximab, interleukin-6 inhibition or Janus kinase inhibitors demonstrate higher severe infection risks vs. TNF inhibitors, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
November 17, 2024
2 min read
Save

Withholding JAK, IL-17 inhibitors fails to improve COVID-19 vaccine booster response

Withholding JAK, IL-17 inhibitors fails to improve COVID-19 vaccine booster response

WASHINGTON — Withholding Janus kinase or interleukin-17 inhibitors from patients with rheumatoid arthritis or spondyloarthritis does not significantly benefit COVID-19 booster response, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
November 16, 2024
2 min read
Save

Herpes zoster vaccine effective, shows ‘no signs’ of increased severe flare risk in lupus

Herpes zoster vaccine effective, shows ‘no signs’ of increased severe flare risk in lupus

WASHINGTON — Herpes zoster vaccination is effective in patients with systemic lupus erythematosus and multiple sclerosis, without increasing the risk for severe lupus flares, according to data presented at ACR Convergence 2024.

SPONSORED CONTENT
November 11, 2024
2 min read
Save

Rheumatic disease activity at time of COVID-19 vaccination drives subsequent flare risk

Rheumatic disease activity at time of COVID-19 vaccination drives subsequent flare risk

Higher disease activity and medication reduction at COVID-19 vaccination increase the risk for subsequent flares in patients with rheumatic and musculoskeletal diseases, according to data published in Annals of the Rheumatic Diseases.

SPONSORED CONTENT
November 06, 2024
2 min read
Save

Rural patients with AIRDs have 24% higher post-COVID mortality risk vs urban population

Rural patients with AIRDs have 24% higher post-COVID mortality risk vs urban population

Patients with autoimmune or inflammatory rheumatic diseases living in rural areas demonstrate a 24% higher mortality risk after SARS-CoV-2 infection vs. those in urban areas, according to data published in Arthritis Care & Research.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails